INNOVADERM CRO IS NOW INDERO.

Systemic Sclerosis Case Study

Click here for a PDF version of this case study Indero helped optimize recruitment and logistics for this systemic sclerosis (SSc) study. Outcomes Effective study design and patient management leading to 96% patient retention Patient recruitment was completed on time without any advertisement despite longer timelines associated with academic sites and the institutional burden   […]

Urticaria Case Study

Click here for a PDF version of this case study Outcomes Indero successfully rescued this urticaria study and this resulted in: Recruitment on Time The study was completed successfully, demonstrating Indero’s ability to manage early phase international clinical trials. Client Feedback “We have had strong project director support which contributed to the successful collaboration between the […]

Atopic Dermatitis (AD) Rescue Case Study

Click here for a PDF version of this case study Indero supported the rescue of a Phase 2a atopic dermatitis trial. Outcomes Indero successfully rescued this AD study, resulting in: 215% enrollment increase in half the time Dramatic improvement of site engagement   Study Characteristics Study Phase: 2a Patient population: Atopic dermatitis IP Route of administration: […]

A Success Story: Pre-IND and IND Support for an Alopecia Areata Investigational Product

Click here for a PDF version of this case study Indero’s support helped this alopecia areata (AA) product progress seamlessly to clinical stages. Steps and Actions Taken Pre-Investigational New Drug (IND) Submission Clinical section development: Prepared clinical sections of the pre-IND and provided clinical trial design suggestions Synopsis writing: Drafted the synopsis for their first […]

Plaque Psoriasis Case Study

Click here for a PDF version of this case study Outcomes Indero successfully managed this plaque psoriasis study and this resulted in: Enrollment completion 5 months earlier than planned   Study Characteristics Study Phase: II Patient Population: Plaque Psoriasis IP Route of Administration: Systemic Total Enrollment: 224 patients, 59 sites (North America & Europe)​   […]

Nimbus Testimonial

Innovaderm is proud of its partnership with Nimbus Therapeutics for an investigational oral TYK2 inhibitor, in a Phase 2b trial for patients with moderate-to-severe psoriasis. Innovaderm’s reputed teams once again proved their expertise throughout the whole project, from the study design all the way to the trial reports, under tight timelines. “There are many CRO […]

“Working with Indero for our alopecia areata trial has been a smooth and exceptional experience (…)” – An Inmagene Biopharmaceuticals Testimonial

Our remarkable team has received high praise from yet another satisfied customer! “Working with Innovaderm for our alopecia areata trial has been a smooth and exceptional experience, marked by their extensive expertise, proactive approach, and seamless collaboration.” Duong Nguyen, Head of Clinical Operations at Inmagene Biopharmaceuticals. “Innovaderm’s profound understanding of alopecia areata and their forward-thinking strategy […]

Success Story: Support for Vitiligo Pre-IND Submission and FDA Meeting Preparation

Click here for a PDF version of this case study Project Overview The client sought support for their pre-IND (Investigational New Drug) submission and development program. Our goal was to contribute to the clinical section of the pre-IND submission package and prepare clinical questions for their Vitiligo asset. Steps and Actions Taken Step 1: Pre-IND Submission […]

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.